NCT01803282 Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01803009 Patients' Opinions and Responses to the National Cancer Institute's Colorectal Cancer Risk Assessment Tool Status COMPLETED Phase NA
NCT01802645 Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases Status UNKNOWN Phase PHASE2
NCT01801930 A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer Status COMPLETED Phase PHASE1
NCT01801085 Nursing and Pharmacy Time for Delivering Xeloda® Versus 5-Fluoruracil Regimens Status TERMINATED Phase N/A
NCT01792882 Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples Status WITHDRAWN Phase N/A
NCT01791140 BEVERLY-C: An Observational Study of Avastin (Bevacizumab) in First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer Status COMPLETED Phase N/A
NCT01781650 A Comparison of Air Insufflation, Water Immersion and Water Exchange Colonoscopy in Diagnostic Patients Status COMPLETED Phase NA
NCT01780818 A Comparison of Air Insufflation, Water Immersion and Water Exchange Colonoscopy in CRC Screening Status COMPLETED Phase NA
NCT01778192 A Randomized Prospective Trial Comparing Polyethylene Glycol and Sodium Picosulphate With Magnesium Citrate Status COMPLETED Phase PHASE3
NCT01776307 A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01775644 An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE) Status COMPLETED Phase N/A
NCT01773980 CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening Status COMPLETED Phase N/A
NCT01763450 Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT01762813 Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer Status RECRUITING Phase N/A
NCT01762293 A Study of Famitinib in Patients With Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01761240 Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC Status COMPLETED Phase PHASE1
NCT01759238 Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer Status TERMINATED Phase PHASE2